Fig. 5From: Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of lenalidomide in human plasma and its application on bioequivalence studiesMean plasma concentration (ng/mL) profile of lenalidomide following 25 mg oral dose of test (T) and reference (R) preparation to 12 healthy human volunteersBack to article page